Pfizer Rap Sheet

[link to www.corp-research.org (secure)]

$205 million to settle the tens of thousands of valve lawsuits that had been filed against it.

$10.75 million to settle Justice Department charges that it lied to regulators in seeking approval for the valves

$9 million to monitor valve patients at Veterans Administration hospitals or pay for removal of the device.

$60 million settlement of a class-action suit brought by users of Rezulin

$894 million to settle the lawsuits that had been filed in connection with Bextra and Celebrex.

$136 million to settle a class-action case and other civil suits that had been brought on behalf of consumers and state and local governments. Later settlements brought the amount to more than $150 million.

$49 million to settle charges that one of its subsidiaries defrauded the federal Medicaid program by overcharging for its cholesterol-lowering drug Lipitor.

$784 million to settle allegations that Wyeth underpaid rebates to Medicaid on two of its drugs.

$107 million for charging excessive and unfair prices for an epilepsy drug.

racketeering fraud in its marketing of Neurontin; the judge in the case subsequently ordered the company to pay $142 million in damages.

$34.7 million to settle federal charges relating to the illegal marketing of its Genotropin human growth hormone.

$2.3 billion to resolve criminal and civil charges relating to the improper marketing of Bextra and three other medications.

$35 million settlement of Rapamune charges brought by more than 40 state attorneys general.

$45 million settlement with Pfizer to resolve charges that its subsidiaries, especially Wyeth, had bribed overseas doctors and other healthcare professionals to increase foreign sales.

$3.1 million to settle EPA charges that the company seriously damaged the Delaware River by failing to install pollution-control equipment at one of its plants in Pennsylvania.

$1.5 million as part of a consent decree with the EPA in connection with its dumping at a toxic waste site in Rhode Island.

$538,000 for failing to properly monitor wastewater discharged from its plant in Parsippany.

$22,500 to settle EPA claims that the company failed to properly notify state and federal officials of a 2002 chemical release from its plant in Groton that seriously injured several employees and necessitated a major emergency response.

$46,250 to settle charges that its Pharmacia & Upjohn operation had violated federal air pollution rules at its plant in Kalamazoo, Michigan.

$75 million to settle some of the lawsuits that had been brought in Nigerian courts.The U.S. case was settled in 2011 for an undisclosed amount.

$1.37 million to a former Pfizer scientist who claimed she was sickened by a genetically engineered virus at a company lab and was then fired for raising safety concerns.

Global genocide $?